Intuitive Surgical (NASDAQ:ISRG) Rating Lowered to “Hold” at Erste Group Bank

Intuitive Surgical (NASDAQ:ISRG) was downgraded by research analysts at Erste Group Bank from a “strong-buy” rating to a “hold” rating in a note issued to investors on Monday,Zacks.com reports.

Other equities analysts have also recently issued reports about the stock. Jefferies Financial Group upped their price target on shares of Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. Raymond James boosted their price objective on shares of Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a research report on Friday, January 24th. BTIG Research boosted their price objective on shares of Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research report on Tuesday, November 26th. Royal Bank of Canada boosted their price objective on shares of Intuitive Surgical from $611.00 to $641.00 in a research report on Monday, January 27th. Finally, Bernstein Bank boosted their price objective on shares of Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a research report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $611.86.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $483.95 on Monday. Intuitive Surgical has a 1 year low of $364.17 and a 1 year high of $616.00. The stock has a market capitalization of $172.37 billion, a P/E ratio of 75.50, a P/E/G ratio of 5.85 and a beta of 1.43. The company’s fifty day moving average is $565.43 and its two-hundred day moving average is $531.90.

Insider Transactions at Intuitive Surgical

In related news, EVP Brian Edward Miller sold 8,900 shares of the firm’s stock in a transaction on Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the transaction, the executive vice president now directly owns 5,758 shares in the company, valued at $2,793,033.06. This trade represents a 60.72 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Robert Desantis sold 11,545 shares of the firm’s stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total value of $5,763,494.90. Following the transaction, the executive vice president now owns 5,224 shares in the company, valued at $2,607,925.28. This trade represents a 68.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 33,754 shares of company stock valued at $17,691,621. 0.90% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Intuitive Surgical

A number of hedge funds have recently added to or reduced their stakes in the stock. 111 Capital bought a new stake in Intuitive Surgical in the fourth quarter valued at $1,173,000. Wealth Enhancement Advisory Services LLC increased its holdings in shares of Intuitive Surgical by 69.4% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 264,033 shares of the medical equipment provider’s stock valued at $137,814,000 after purchasing an additional 108,153 shares during the period. Lansforsakringar Fondforvaltning AB publ acquired a new position in shares of Intuitive Surgical during the fourth quarter valued at $109,345,000. PKO Investment Management Joint Stock Co acquired a new position in shares of Intuitive Surgical during the fourth quarter valued at $1,566,000. Finally, IronOak Wealth LLC. acquired a new position in shares of Intuitive Surgical during the fourth quarter valued at $1,595,000. 83.64% of the stock is currently owned by institutional investors.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.